Paroxetine vs Bumetanide: side-by-side comparison
Paroxetine (Selective serotonin reuptake inhibitor (SSRI)) and Bumetanide (Loop diuretic) belong to different therapeutic classes and are rarely substitutes for each other. The comparison is useful when a single patient is weighing both options for adjacent or overlapping needs.
| Property | Paroxetine | Bumetanide |
|---|---|---|
| Therapeutic class | Selective serotonin reuptake inhibitor (SSRI) | Loop diuretic |
| CAS | 61869-08-7 | 28395-03-1 |
| ATC | N06AB05 | C03CA02 |
| Molecular weight | 329.37 g/mol | 364.42 g/mol |
| Brands with this active ingredient | 1 | 1 |
What they share
Paroxetine and Bumetanide share the common regulatory framework for prescription active ingredients, bioequivalence standards for generics, and pharmacist oversight. Beyond that, points in common are limited.
Key differences
Paroxetine acts by a different mechanism than Bumetanide, with indications that barely overlap. Comparing the two is useful when a clinician has mentioned both in the same context or the patient wants to understand why one was prescribed instead of the other.
Mechanisms compared
Paroxetine: Paroxetine selectively inhibits the serotonin reuptake transporter, increasing serotonin availability at the synapse. Bumetanide: Bumetanide blocks the Na-K-2Cl cotransporter in the thick ascending limb of the loop of Henle, producing potent natriuresis and diuresis.
Indications compared
Paroxetine: Paroxetine is approved for major depressive disorder, generalised anxiety disorder, social anxiety disorder, panic disorder, obsessive-compulsive disorder and post-traumatic stress disorder, with regional variation. Bumetanide: Bumetanide is approved for oedema in heart failure, hepatic cirrhosis or chronic kidney disease, and for refractory oedema unresponsive to other diuretics.
Safety profile
Paroxetine: Common adverse effects include nausea, sexual dysfunction (more pronounced than with most SSRIs), weight gain, sleep disturbance, fatigue and anticholinergic symptoms. Bumetanide: Common adverse effects include hypokalaemia, hyponatraemia, hypomagnesaemia, dehydration, hyperuricaemia, hyperglycaemia, ototoxicity (rare, dose-dependent) and orthostatic hypotension.
Frequently asked questions
Is Paroxetine better than Bumetanide? ▾
Paroxetine and Bumetanide are not "better or worse" — they treat different things. The sensible question is which fits your specific need.
Can Paroxetine and Bumetanide be combined? ▾
Whether they can be combined depends on the indications and the interaction profile of each. If both are in a single prescription, the prescriber has weighed it; in self-medication they should never be combined.
Do they have the same side-effect profile? ▾
No — they belong to different classes and have distinct side-effect profiles. Each has its own prescribing information.
Products with Paroxetine
Products with Bumetanide
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.